In Vivo is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Aluminum-Containing Antiperspirant Renal Warning Mandated By FDA

This article was originally published in The Rose Sheet

Executive Summary

Antiperspirants containing aluminum will be required to carry a renal dysfunction warning due to risks associated with possible increased absorption of the ingredient, according to the OTC Antiperspirant Drug Products Final Monograph
Advertisement

Related Content

P&G Goes Native In Acquisition That Aligns With Peltz' Vision
P&G Goes Native In Acquisition That Aligns With Peltz' Recommendations
P&G Goes Native In Acquisition That Aligns With Peltz' Recommendations
Antiperspirant Market Drivers Include Natural Options, Innovative Benefits
Antiperspirant Sales Drivers Smell Natural, With Additional Benefits
Skin-Absorption Data Needed On Aluminum In Cosmetics – SCCS
Antiperspirant Use Leads To Excessive Aluminum Exposure, Study Suggests
Antiperspirant Labeling Determined Appropriate In FDA Petition Denial
Antiperspirant Labeling Determined Appropriate In FDA Petition Denial
Advertisement
UsernamePublicRestriction

Register

RS011254

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel